The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Anticipated For The Retinal Disorder Treatment Market Over The Period 2026–2030?
The retinal disorder treatment market size has experienced strong growth in recent years. This market is projected to expand from $13.69 billion in 2025 to $14.86 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.6%. Factors contributing to its historical expansion include the increasing prevalence of age-related macular degeneration, a rising global diabetic population, the expansion of ophthalmology clinics and specialty hospitals, innovations in retinal imaging technologies, and enhanced awareness of retinal conditions.
The retinal disorder treatment market size is expected to experience substantial expansion over the next few years. It is projected to grow to $21.27 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 9.4%. This anticipated growth during the forecast period can be attributed to several factors, including the creation of long-acting retinal drugs, increasing approvals of new biologics and gene therapies, enhanced access to eye care in developing markets, rising investment in ophthalmic research, and a growing demand for customized retinal treatments. Prominent trends for the forecast period involve the expanding adoption of anti-VEGF therapies, a shift towards less invasive retinal procedures, an increasing preference for sustained-release drug formulations, the broadening of combination therapy approaches, and a rising utilization of home-based vision monitoring tools.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12701&type=smp
Which Economic Or Industry Drivers Are Impacting The Retinal Disorder Treatment Market?
The escalating occurrence of diabetes is projected to fuel the expansion of the retinal disorder treatment market moving forward. Diabetes is a persistent health condition defined by elevated blood glucose levels, which results from the body’s inability to produce sufficient insulin or effectively utilize the insulin it generates. Diabetic retinopathy stands as the most common retinal disorder among individuals with diabetes, arising from damage to the retina’s blood vessels, potentially leading to bleeding, fluid leakage, and the proliferation of new blood vessels. Retinal disorder treatment utilizes lasers to seal compromised blood vessels or eliminate abnormal ones. Illustratively, in June 2024, the National Health Service, a UK-based government department, disclosed that in 2023, the NHS identified over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes. This increased the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP, to 3,615,330, representing a considerable rise compared to 3,065,825 in 2022. Consequently, the increasing prevalence of diabetes is actively propelling the growth of the retinal disorder treatment market.
How Is The Retinal Disorder Treatment Market Divided Into Its Major Segments?
The retinal disorder treatment market covered in this report is segmented –
1) By Type: Macular Degeneration, Diabetic Retinopathy, Other Types
2) By Dosage Form: Gels, Eye Solutions, Capsules And Tablets, Eye Drops, Ointments
3) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
Subsegments:
1) By Macular Degeneration: Dry Macular Degeneration, Wet Macular Degeneration
2) By Diabetic Retinopathy: Non-Proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy
3) By Other Types: Retinal Detachment, Retinitis Pigmentosa, Uveitis, Other Retinal Disorders
How Are Trends Transforming The Retinal Disorder Treatment Market Landscape?
Key companies active in the retinal disorder treatment market are introducing advanced products, like geographic atrophy treatments, to serve wider customer bases, enhance sales, and boost revenue. Current treatment strategies for geographic atrophy concentrate on alleviating symptoms, decelerating the disease’s advancement, and assisting patients with visual impairment. For example, in August 2023, Astellas Pharma Inc., a pharmaceutical company based in Japan, announced the U.S. Food and Drug Administration (FDA) approval of IZERVAY. Being a novel complement C5 inhibitor, IZERVAY sets itself apart as the only approved treatment for geographic atrophy (GA) that has demonstrated a statistically significant reduction (p<0.01) in the rate of GA progression at the 12-month primary endpoint in two Phase 3 clinical trials. This distinct quality confirms IZERVAY (avacincaptad pegol intravitreal solution) as an indicated and potent therapy for GA associated with age-related macular degeneration (AMD).
Who Are The Prominent Organizations Shaping The Retinal Disorder Treatment Market?
Major companies operating in the retinal disorder treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, Regeneron Pharmaceuticals Inc., Genentech Inc., Santen Pharmaceutical Co. Ltd., Apellis Pharmaceuticals Inc., Alimera Sciences Inc., Ocular Therapeutix Inc., EyePoint Pharmaceuticals Inc., Adverum Biotechnologies Inc., Kodiak Sciences Inc., Acucela Inc., IVERIC bio Inc., Oxurion NV, Graybug Vision Inc., Clearside Biomedical Inc., Ophthotech Corporation, Opthea Limited, PanOptica Inc., ThromboGenics NV
Read the full retinal disorder treatment market report here:
https://www.thebusinessresearchcompany.com/report/retinal-disorder-treatment-global-market-report
What Are The Top-Performing Regions Within The Retinal Disorder Treatment Market?
North America was the largest region in the retinal disorder treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the retinal disorder treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Retinal Disorder Treatment Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=12701&type=smp
Browse Through More Reports Similar to the Global Retinal Disorder Treatment Market 2026, By The Business Research Company
Retinal Disorder Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/retinal-disorder-treatment-global-market-report
Optic Nerve Disorders Treatment Market Report 2026
Retinal Biologics Market Report 2026
https://www.thebusinessresearchcompany.com/report/retinal-biologics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model